Alimera Sciences Stock Price, News & Analysis
Company Description
Alimera Sciences (NASDAQ: ALIM) is a publicly traded pharmaceutical preparation manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $301.3M, ranking #4,043 among all listed U.S. companies by market cap.
ALIM stock has gained 67.9% over the past year. Shares last traded at $5.54.
This page provides a comprehensive overview of ALIM stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Alimera Sciences (ALIM) stock last traded at $5.54. Over the past 12 months, the stock has gained 67.9%. At a market capitalization of $301.3M, ALIM is classified as a small-cap stock with approximately 54.4M shares outstanding.
Latest News
Alimera Sciences has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, earnings, conferences. View all ALIM news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ALIM Company Profile & Sector Positioning
Alimera Sciences (ALIM) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.